IV Equipment Market Size, Share, Growth, and Industry Analysis, By Types (IV Catheters, Administration Sets, Infusion Pumps, Securement Devices, Stopcocks & Check Valves, Drip Chambers, Needleless Connectors, Others), By Applications Covered (Hospitals & Clinics, Home Care, Ambulatory Care Centers), Regional Insights and Forecast to 2034

IV Equipment Market Size

The Global IV Equipment Market size was valued at USD 11609.63 million in 2024, projected to reach USD 12533.75 million in 2025, and is expected to hit approximately USD 13531.44 million by 2026, surging further to USD 24971.63 million by 2034. This growth represents a strong CAGR of 7.96% during the forecast period of 2025–2034. Around 41% of the global market demand comes from hospitals and clinics, while ambulatory surgical centers contribute nearly 29%, and homecare settings account for about 20%. The rising prevalence of chronic illnesses, increasing surgical procedures, and the growing adoption of smart infusion systems are significantly driving demand.

In the US Market, IV equipment accounts for over 36% of global sales, supported by advanced healthcare infrastructure, high hospitalization rates, and expanding use of precision infusion pumps. The region’s strong regulatory framework and increasing adoption of disposable IV products are further boosting product innovation and distribution.

Key Findings

• Market Size - Valued at 12533.75M in 2025, expected to reach 24971.63M by 2034, growing at a CAGR Of 7.96%.
• Growth Drivers - 41% increase in chronic illness treatments and 38% growth in smart IV system adoption boosting market expansion globally.
• Trends - 44% rise in digital IV systems and 33% surge in disposable IV device manufacturing across emerging economies.
• Key Players - B. Braun Melsungen AG, Baxter International Inc., Fresenius SE & Co. KGaA, Becton, Dickinson and Company, Terumo Corporation.
• Regional Insights - North America holds 38% share driven by advanced healthcare infrastructure, Europe 27% supported by safety IV innovations, Asia-Pacific 25% from rapid hospital expansion, and Middle East & Africa 10% fueled by rising healthcare modernization.
• Challenges - 35% of manufacturers face regulatory delays and 28% report supply chain inefficiencies affecting product delivery.
• Industry Impact - 39% improvement in treatment efficiency and 26% reduction in infusion-related infections due to advanced IV equipment adoption.
• Recent Developments - 36% of companies launched smart infusion systems and 29% expanded R&D for safety-based IV innovations globally.

The IV Equipment Market is an essential component of global healthcare, underpinning a wide range of therapeutic and clinical procedures. This market comprises infusion pumps, catheters, cannulas, needleless connectors, IV sets, and accessories used to deliver fluids, nutrients, and medications directly into patients’ veins. Approximately 48% of demand comes from the treatment of chronic diseases such as diabetes, cancer, and cardiovascular disorders, which require long-term IV therapy. Meanwhile, surgical procedures contribute nearly 32% of usage, reflecting the growing dependence on precise fluid administration. Technological innovation continues to reshape the IV Equipment Market, with about 37% of new product developments focusing on smart infusion systems that integrate digital monitoring and AI-based flow control. Safety-engineered IV sets represent roughly 26% of total market sales, driven by rising awareness about infection control and needle-stick injury prevention. In terms of end-user distribution, hospitals dominate with around 55% market share, followed by ambulatory surgical centers and homecare facilities collectively contributing about 38%. The increasing shift toward portable and patient-friendly devices is also stimulating demand in outpatient care settings. Additionally, the growing geriatric population and a 43% increase in home-based intravenous therapy adoption are accelerating the market’s evolution toward more automated and efficient solutions.

IV Equipment Market Trends

The IV Equipment Market is witnessing rapid transformation due to evolving clinical requirements, digital integration, and the growing preference for safe and efficient infusion delivery systems. Approximately 46% of hospitals globally are adopting smart infusion pumps that reduce medication errors by up to 30%. Disposable and single-use IV products now make up nearly 42% of the total demand, largely due to rising infection control measures. Moreover, the use of needleless connectors has surged by around 28% as healthcare facilities aim to improve safety standards. Automated infusion technologies account for about 33% of market share, with increasing demand from critical care and oncology departments. Home infusion therapy has gained traction, representing approximately 21% of IV equipment utilization globally, supported by a growing focus on remote patient management. Regional manufacturers are expanding production capacities, with nearly 35% of firms investing in advanced materials and microfluidic technologies to enhance device precision and durability. Additionally, around 40% of healthcare providers are integrating IoT-enabled monitoring systems for real-time tracking of IV performance. This digital shift is improving clinical efficiency while reducing operational costs, positioning the IV Equipment Market for strong expansion across both developed and emerging healthcare economies.

IV Equipment Market Dynamics

OPPORTUNITY

Expansion of Home-Based Healthcare Services

The IV Equipment Market is witnessing significant opportunities through the rapid expansion of home-based healthcare services, which account for nearly 27% of global IV usage. Rising chronic disease prevalence and patient preference for home-based treatment have increased demand for portable infusion pumps by 34%. Additionally, 29% of healthcare providers have integrated remote IV monitoring solutions to enhance patient safety and reduce hospital readmissions. Growing awareness about cost-effective outpatient care models, supported by a 31% increase in home infusion therapy adoption, is creating lucrative growth avenues for manufacturers of compact and user-friendly IV devices.

DRIVERS

Growing Demand for Smart Infusion Systems

The demand for advanced IV equipment is primarily driven by the increasing use of smart infusion systems that improve accuracy and reduce human errors. Approximately 44% of hospitals globally have adopted smart infusion pumps, enhancing dosing precision by 35%. Integration of digital flow monitoring and alarm systems has improved patient safety levels by 38%. Furthermore, 41% of healthcare facilities in developed regions have transitioned to automated IV administration solutions, minimizing manual intervention. This technological transformation is reshaping hospital workflows and fostering consistent market growth for high-performance IV devices worldwide.

RESTRAINTS

"High Equipment Costs and Maintenance Challenges"

Despite strong market growth, the IV Equipment Market faces notable restraints due to high procurement and maintenance costs. Nearly 33% of healthcare providers cite financial limitations as a barrier to adopting advanced IV systems. Around 28% of hospitals in emerging regions continue to rely on conventional IV setups due to affordability constraints. Complex calibration and sterilization processes increase operational expenses by 25%, particularly in smaller clinics. In addition, 30% of institutions report challenges in staff training and device management, further hindering widespread implementation of technologically advanced infusion systems.

CHALLENGE

"Regulatory and Supply Chain Limitations"

Regulatory compliance and fragmented supply chains remain critical challenges for the IV Equipment Market. Nearly 37% of manufacturers report delays in product approvals due to stringent device safety standards. Around 29% face disruptions in component sourcing, affecting production timelines. Regional disparities in import regulations impact nearly 22% of market participants, particularly in low-income regions. Additionally, inconsistent global standardization for IV safety devices creates operational inefficiencies for 24% of producers. These challenges collectively slow down product innovation cycles and restrict the global accessibility of advanced IV therapy equipment.

Segmentation Analysis

The Global IV Equipment Market, valued at USD 11609.63 million in 2024 and projected to reach USD 12533.75 million in 2025, is expected to rise to USD 24971.63 million by 2034, expanding at a CAGR of 7.96% during 2025–2034. Segmentation by type and application reveals a highly diversified structure driven by increasing clinical demand and technological integration. Infusion pumps lead with 32% of the global share, followed by IV catheters at 25%, administration sets at 14%, and needleless connectors contributing 10%. On the application side, hospitals and clinics dominate with 56% share, while home care and ambulatory centers represent 27% and 17%, respectively, emphasizing the market’s growing shift toward patient-centric and home-based infusion therapies.

By Type

IV Catheters

IV catheters are essential for continuous and controlled intravenous delivery of fluids and medications. Representing 25% of the total market, they are widely used in surgical, emergency, and chronic care applications. Their demand is primarily driven by rising hospital admissions and the growing preference for safety-engineered catheters.

IV Catheters held a significant share in the IV Equipment Market, accounting for USD 3,133.43 million in 2025, representing 25% of the total market. This segment is expected to grow at a CAGR of 7.3% from 2025 to 2034, supported by increasing infection-control initiatives and enhanced catheter materials.

Major Dominant Countries in the IV Catheters Segment

• United States led with USD 940.02 million, holding a 30% share, driven by rising surgical cases and advanced safety standards.
• Germany captured 22% share due to growing hospital modernization projects.
• India accounted for 16% share with rapid expansion of healthcare facilities.

Administration Sets

Administration sets form a critical component of IV delivery systems, facilitating the safe transfer of fluids. They represent around 14% of the total market share, used extensively in hospitals and ambulatory settings.

Administration Sets reached USD 1,754.73 million in 2025, representing 14% share, projected to expand at a CAGR of 7.1% during 2025–2034, driven by increased procedural volumes and rising preference for disposable products.

Major Dominant Countries in the Administration Sets Segment

• United States led with USD 526.41 million, 30% share due to strong demand for sterile IV consumables.
• China held 24% share with large-scale production facilities.
• France accounted for 17% share supported by infection control compliance.

Infusion Pumps

Infusion pumps are advanced electronic systems that control the rate of fluid administration, dominating the market with 32% share. Their precision and integration with digital health systems have improved patient safety and care efficiency.

Infusion Pumps held the largest share, accounting for USD 4,010.80 million in 2025, representing 32% of the market, expected to grow at a CAGR of 8.2% from 2025 to 2034, driven by smart pump technology and automation.

Major Dominant Countries in the Infusion Pumps Segment

• United States led with USD 1,203.24 million, 30% share due to high adoption of smart infusion technology.
• Japan held 21% share supported by advanced R&D programs.
• Germany accounted for 17% share due to strong clinical innovation infrastructure.

Securement Devices

Securement devices prevent catheter displacement and reduce infection risks, representing 8% of the total IV equipment market. They are increasingly adopted due to their role in patient comfort and safety.

Securement Devices generated USD 1,002.70 million in 2025, representing 8% share, expected to grow at 7.6% CAGR, driven by growing infection-prevention awareness and regulatory guidelines on catheter stabilization.

Major Dominant Countries in the Securement Devices Segment

• United States led with USD 300.81 million, 30% share supported by advanced hospital safety protocols.
• United Kingdom held 22% share with increasing usage in wound care and infusion therapy.
• Australia accounted for 15% share due to higher adoption in long-term care centers.

Stopcocks & Check Valves

Stopcocks and check valves are vital for precise control in fluid management and multi-line infusion systems. They make up around 6% of total market share.

Stopcocks & Check Valves were valued at USD 752.02 million in 2025, representing 6% share, expanding at 7.4% CAGR due to increasing critical care demand and multi-infusion therapy use.

Major Dominant Countries in the Stopcocks & Check Valves Segment

• United States led with USD 225.60 million, 30% share due to critical care utilization.
• Germany held 23% share supported by high ICU infrastructure growth.
• Japan accounted for 17% share with strong focus on precision medical devices.

Drip Chambers

Drip chambers regulate and monitor fluid flow within IV sets, accounting for 5% of the total market. They are crucial for preventing air embolism and ensuring steady administration.

Drip Chambers were valued at USD 626.69 million in 2025, holding a 5% share, expected to grow at 6.8% CAGR from 2025 to 2034, driven by increased clinical procedure volumes.

Major Dominant Countries in the Drip Chambers Segment

• United States led with USD 187.90 million, 30% share due to strong hospital network penetration.
• China captured 25% share through mass manufacturing efficiency.
• India held 16% share supported by rising public healthcare expenditure.

Needleless Connectors

Needleless connectors enhance safety by minimizing contamination and reducing needle-stick injuries, accounting for 10% of total market demand. Their use has expanded rapidly across hospitals and intensive care units.

Needleless Connectors held USD 1,253.38 million in 2025, representing 10% share, growing at 8.0% CAGR from 2025 to 2034, supported by 40% higher adoption in developed healthcare systems.

Major Dominant Countries in the Needleless Connectors Segment

• United States led with USD 376.01 million, 30% share supported by advanced infection control practices.
• Germany captured 22% share with high demand in ICUs.
• Japan held 18% share with widespread adoption in tertiary hospitals.

Others

This category includes IV accessories such as filters, extension sets, and flow regulators, accounting for 5% of total market share, primarily used in specialized procedures.

Others segment was valued at USD 626.69 million in 2025, representing 5% share, growing at 6.9% CAGR due to increasing usage in pediatric and oncology applications.

Major Dominant Countries in the Others Segment

• United States led with USD 187.90 million, 30% share due to high use in oncology infusion systems.
• France captured 22% share supported by home infusion care growth.
• India held 18% share due to expanding specialty care facilities.

By Application

Hospitals & Clinics

Hospitals and clinics remain the primary end-users, accounting for 56% of total market share. They rely heavily on IV equipment for surgeries, emergency care, and chronic disease management.

Hospitals & Clinics accounted for USD 7,018.90 million in 2025, representing 56% share, expanding at 7.8% CAGR, driven by increased patient admissions and continuous device replacement cycles.

Major Dominant Countries in the Hospitals & Clinics Segment

• United States led with USD 2,105.67 million, 30% share supported by advanced healthcare infrastructure.
• Germany captured 22% share with robust hospital networks.
• China held 18% share due to rising hospitalization rates.

Home Care

Home care applications are expanding rapidly, supported by technological advancements and patient preference for home-based treatments. They account for 27% of total IV equipment market demand.

Home Care generated USD 3,384.11 million in 2025, representing 27% share, growing at 8.3% CAGR, driven by rising chronic illness management and increasing telemedicine adoption.

Major Dominant Countries in the Home Care Segment

• United States led with USD 1,015.23 million, 30% share supported by telehealth and home infusion programs.
• Japan captured 23% share with elderly care support systems.
• India held 17% share with growth in private home healthcare providers.

Ambulatory Care Centers

Ambulatory care centers are witnessing increasing IV equipment adoption due to day-care procedures and reduced hospital stays, holding a 17% share of the total market.

Ambulatory Care Centers reached USD 2,132.74 million in 2025, representing 17% share, projected to grow at 7.4% CAGR, driven by outpatient service expansion and cost-efficient treatments.

Major Dominant Countries in the Ambulatory Care Centers Segment

• United States led with USD 639.82 million, 30% share due to expanding day-surgery centers.
• United Kingdom captured 22% share with enhanced outpatient care investments.
• Australia held 16% share driven by high healthcare spending on ambulatory infrastructure.

IV Equipment Market Regional Outlook

The Global IV Equipment Market, valued at USD 11609.63 million in 2024, is projected to reach USD 12533.75 million in 2025 and is expected to hit USD 24971.63 million by 2034, growing at a CAGR of 7.96% during 2025–2034. The regional distribution indicates that North America leads with 38% of the total share, followed by Europe with 27%, Asia-Pacific with 25%, and the Middle East & Africa accounting for 10%. Each region exhibits unique growth drivers such as technological advancement, healthcare expansion, and rising surgical and infusion therapy demands.

North America

North America dominates the IV Equipment Market, supported by advanced healthcare infrastructure, high hospital expenditure, and increasing adoption of smart infusion systems. The region holds the largest share due to its well-established medical device industry and growing patient population requiring long-term intravenous therapy. Nearly 42% of hospitals across the U.S. have implemented automated infusion technologies.

North America held the largest share in the IV Equipment Market, accounting for USD 4,762.82 million in 2025, representing 38% of the global market. This growth is primarily driven by high chronic disease prevalence, increasing outpatient infusion centers, and innovation in needleless and wireless IV technologies.

North America - Major Dominant Countries in the IV Equipment Market

• United States led the North American market with a 30% share in 2025, driven by widespread adoption of advanced infusion systems and strong R&D infrastructure.
• Canada accounted for 5% share due to rising healthcare spending and technological integration in hospital networks.
• Mexico held 3% share, supported by expanding medical device import activity and healthcare modernization.

Europe

Europe represents 27% of the global IV Equipment Market, fueled by strong hospital networks, regulatory standardization, and high adoption of disposable and safety-engineered IV devices. Demand is also driven by the rising incidence of chronic illnesses and a growing geriatric population requiring long-term infusion care.

Europe accounted for USD 3,384.11 million in 2025, representing 27% of total market share. This regional growth is supported by increased biosafety regulations, innovation in IV product design, and expanding public health expenditure across key EU countries.

Europe - Major Dominant Countries in the IV Equipment Market

• Germany led the European market with a 10% share due to advanced manufacturing facilities and a robust clinical research base.
• France accounted for 9% share, driven by a growing patient base and hospital infrastructure development.
• United Kingdom held 8% share supported by widespread adoption of digital health infusion monitoring systems.

Asia-Pacific

Asia-Pacific holds 25% of the total IV Equipment Market, driven by large patient populations, expanding healthcare access, and increasing adoption of cost-effective infusion products. Technological advancements and government healthcare initiatives are fostering strong demand for IV sets and infusion pumps across the region.

Asia-Pacific accounted for USD 3,133.43 million in 2025, representing 25% of the global market. Growth is propelled by rapid hospital construction, higher surgical volumes, and increased use of disposable IV components for infection prevention in emerging economies.

Asia-Pacific - Major Dominant Countries in the IV Equipment Market

• China led the Asia-Pacific region with 12% share, supported by mass production capabilities and government healthcare reforms.
• Japan held 8% share with innovation-driven healthcare technology adoption.
• India captured 5% share due to expanding clinical and home infusion therapy markets.

Middle East & Africa

Middle East & Africa contributes 10% to the overall IV Equipment Market, with increasing investments in healthcare infrastructure and the growing adoption of modern infusion systems. Public health initiatives and expanding hospital networks are creating steady demand for IV consumables and automated equipment.

Middle East & Africa reached USD 1,253.38 million in 2025, representing 10% of total market share. Growth is driven by higher healthcare access, modernization of intensive care units, and government focus on advanced medical technology procurement.

Middle East & Africa - Major Dominant Countries in the IV Equipment Market

• Saudi Arabia led the regional market with 4% share due to expanding hospital infrastructure and increased procurement of IV automation systems.
• United Arab Emirates accounted for 3% share, driven by rising healthcare tourism and adoption of high-quality infusion equipment.
• South Africa held 3% share supported by an expanding private healthcare sector and higher chronic disease management rates.

List of Key IV Equipment Market Companies Profiled

Investment Analysis and Opportunities

The IV Equipment Market is witnessing a surge in investment activity driven by healthcare infrastructure development and technological advancement. Approximately 42% of global investments are directed toward smart infusion systems and automated pump technologies. Around 33% of investors focus on developing needleless connectors and safety-engineered IV sets to reduce infection risks. Venture capital funding in IV device startups has risen by nearly 28% over the past year, particularly targeting innovation in digital infusion monitoring. Furthermore, about 36% of hospital procurement budgets are being allocated to IV automation and patient monitoring equipment, indicating high market confidence. The growing preference for disposable IV devices accounts for 31% of new manufacturing expansions globally. Emerging economies contribute nearly 27% of ongoing capacity expansions due to government-backed healthcare modernization programs. Strategic alliances between medical device manufacturers and technology companies have increased by 39%, accelerating product innovation cycles. The integration of IoT and AI-based infusion control systems, representing 24% of new product developments, presents long-term investment opportunities. As global demand for precision drug delivery rises, the IV equipment sector continues to attract strong institutional and private investments, making it one of the most dynamic components of the medical device landscape.

New Products Development

New product development in the IV Equipment Market is driven by innovation in infusion technology and safety design. Around 45% of new products introduced in the past two years integrate digital monitoring systems for precision drug delivery. Nearly 33% of companies have launched needle-free IV systems to minimize contamination and enhance patient safety. Smart infusion pumps account for 38% of all new product releases, offering improved accuracy and connectivity with hospital information systems. About 29% of new developments involve advanced securement devices that reduce catheter displacement incidents by over 25%. Manufacturers are increasingly adopting sustainable materials, with 21% of new IV devices featuring eco-friendly polymers and recyclable components. In addition, 34% of R&D initiatives are centered on portable and wireless infusion devices to meet the growing home-care demand. The adoption of modular IV administration sets, representing 26% of total product innovations, is improving clinical flexibility. With ongoing collaboration between medical device firms and healthcare institutions, the pace of technological advancement in IV systems continues to accelerate, reshaping global infusion therapy practices toward greater automation, safety, and precision.

Recent Developments

• B. Braun Melsungen AG – 2023: Introduced a next-generation safety IV catheter reducing infection rates by 32% and needle-stick incidents by 28% across major hospitals.
• Baxter International Inc. – 2023: Expanded its smart infusion pump series integrating AI-based flow regulation, improving dosage accuracy by 36% in clinical trials.
• Fresenius SE & Co. KGaA – 2024: Launched an advanced digital IV administration platform with 40% faster calibration and improved infusion stability for critical care applications.
• ICU Medical, Inc. – 2024: Developed an upgraded closed system transfer device reducing medication exposure by 35% and minimizing IV contamination risk.
• Terumo Corporation – 2024: Released a portable home infusion kit achieving 30% increase in patient adherence and 25% higher satisfaction in post-acute therapy settings.

Report Coverage

The IV Equipment Market report provides detailed insights into global trends, investment patterns, and emerging opportunities across product types, regions, and applications. It covers approximately 45% of major market participants actively involved in IV infusion system manufacturing. Around 38% of research focuses on smart infusion pumps and safety connectors, while 29% centers on disposable and single-use IV sets. Regional contributions show North America leading with 38% share, Europe at 27%, Asia-Pacific at 25%, and the Middle East & Africa at 10%. The report also highlights the rapid digital transformation within the healthcare industry, where 41% of hospitals are transitioning to IoT-enabled infusion systems. In addition, 33% of global hospitals are implementing automated IV management software for better dosage control. Furthermore, 26% of companies are expanding production capacity in response to increasing hospital demand and home-care integration. By assessing growth opportunities, regulatory trends, and technological advancements, the report provides stakeholders with data-backed insights into the evolving global infusion landscape and future innovation potential.